CLINICAL_TRIALS
trial_result
· 2022-02-21
Clinical Trial Update: GRASPA Treatment for Patients With Acute Myeloblastic Leukemia [Phase 2]
Summary
Phase 2 trial update for GRASPA in patients with Acute Myeloid Leukemia; results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: ERYtech Pharma | Conditions: Acute Myeloid Leukemia | Phase 2 | Status: COMPLETED | Results posted: 2022-02-21